Back to Search
Start Over
Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018).
- Source :
- Journal of Clinical Oncology; 1/10/2024, Vol. 42 Issue 2, p170-179, 15p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 42
- Issue :
- 2
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 174637352
- Full Text :
- https://doi.org/10.1200/JCO.22.02915